Cesare Giovanni Fedele
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cesare Giovanni Fedele has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Antonio Tenorio
Diagnostic Microbiology Service Centro Nacional de Microbiología, Majadahonda, Madrid, Spain
2 shared publicationsA. Tenorio
Alerts and Emergencies Unit, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain,1 Arbovirus and Imported Viral Diseases Laboratory, Diagnostic Microbiology Service, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain2
1 shared publication- Anabel Negredo
Centro Nacional de Microbiología, Instituto de Salud Carlos III, CNM-ISCIII
1 shared publication Carolina Polo
Microbiology Service, Hospital Universitari de Bellvitge, Barcelona, Spain
1 shared publicationElisa Vidal
Hospital Universitario Reina Sofía
1 shared publicationF. Molero
Alerts and Emergencies Unit, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain,1 Arbovirus and Imported Viral Diseases Laboratory, Diagnostic Microbiology Service, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain2
1 shared publication
Latest Publications
- 1 December 2006
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 44 (12) , 4464-4470
Use of Internally Controlled Real-Time Genome Amplification for Detection of Variola Virus and Other Orthopoxviruses Infecting Humans
Smallpox, once a devastating disease caused by Variola virus , a member of the Orthopoxvirus genus, was eradicated in 1980. However, the importance of variola virus infections has been stressed widely in the last few years, particularly following recent social events in the world. Today, variola virus is considered to be one of the most significant agents with potential use as a biological weapon. In this study we developed an internally controlled real-time PCR assay for rapid detection and simultaneous differentiation of variola virus from other orthopoxviruses. The assay is based on TaqMan 3′-minor groove binder (MGB) chemistry and uses generic primers, designed in highly conserved genomic regions of the crmB gene, and three TaqMan MGB probes designed to identify orthopoxviruses, variola virus, and an internal control. The results obtained suggest that the assay is rapid, sensitive, specific, and suitable for the generic detection of orthopoxviruses and the identification of variola virus and avoids false-negative results in a single reaction tube.
- 1 December 2006
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 44 (12) , 4464-4470
Use of Internally Controlled Real-Time Genome Amplification for Detection of Variola Virus and Other Orthopoxviruses Infecting Humans
Smallpox, once a devastating disease caused by Variola virus , a member of the Orthopoxvirus genus, was eradicated in 1980. However, the importance of variola virus infections has been stressed widely in the last few years, particularly following recent social events in the world. Today, variola virus is considered to be one of the most significant agents with potential use as a biological weapon. In this study we developed an internally controlled real-time PCR assay for rapid detection and simultaneous differentiation of variola virus from other orthopoxviruses. The assay is based on TaqMan 3′-minor groove binder (MGB) chemistry and uses generic primers, designed in highly conserved genomic regions of the crmB gene, and three TaqMan MGB probes designed to identify orthopoxviruses, variola virus, and an internal control. The results obtained suggest that the assay is rapid, sensitive, specific, and suitable for the generic detection of orthopoxviruses and the identification of variola virus and avoids false-negative results in a single reaction tube.
- 22 August 2006
- Published by Wiley in Journal of Medical Virology
- Vol. 78 (10) , 1271-1275
Analysis of the transcriptional control region of JC polyomavirus in cerebrospinal fluid from HIV‐negative patients with progressive multifocal leucoencephalopathy
The human polyomavirus JC (JCV) is the causative agent of progressive multifocal leukoencephalopathy (PML), a fatal demyelinating disease of the central nervous system (CNS). JCV has a hyper‐variable non‐coding transcriptional control region (TCR), which contains the origin of replication and the promoters of viral transcription and replication. The archetype form of TCR‐JCV is frequently found in the urine and kidneys of healthy and immunocompromised subjects. However, the rearranged forms, possibly generated by deletion and duplication of segments of the archetype sequence, are found in the peripheral blood, cerebrospinal fluid (CSF), and brain of PML patients. Most experience on this setting has come from the human immunodeficiency virus (HIV) pandemic. Little has been described on the JCV‐TCR sequences from PML‐HIV‐negative patients affected by other immunosuppressive disorders. The aim of this study was to analyze the JCV‐TCR detected in CSF samples from 12 HIV‐negative immunosuppressed patients suffering from PML and to investigate the possible role of genomic organization in the different incidences of PML in HIV‐positive and HIV‐negative patients. The results confirm that the JCV‐TCR rearrangements play a crucial role in the development of PML, although they do not account for the higher frequency of the disease in HIV infection. These data support the hypothesis that, independently of the rearrangement patterns of JCV‐TCR, the direct action of HIV together with other as yet unidentified cellular determinants can be a key to explaining the high rate of PML in HIV infection with respect to other underlying immunosuppressive conditions. J. Med. Virol. 78:1271–1275, 2006.
- 22 August 2006
- Published by Wiley in Journal of Medical Virology
- Vol. 78 (10) , 1271-1275
Analysis of the transcriptional control region of JC polyomavirus in cerebrospinal fluid from HIV‐negative patients with progressive multifocal leucoencephalopathy
The human polyomavirus JC (JCV) is the causative agent of progressive multifocal leukoencephalopathy (PML), a fatal demyelinating disease of the central nervous system (CNS). JCV has a hyper‐variable non‐coding transcriptional control region (TCR), which contains the origin of replication and the promoters of viral transcription and replication. The archetype form of TCR‐JCV is frequently found in the urine and kidneys of healthy and immunocompromised subjects. However, the rearranged forms, possibly generated by deletion and duplication of segments of the archetype sequence, are found in the peripheral blood, cerebrospinal fluid (CSF), and brain of PML patients. Most experience on this setting has come from the human immunodeficiency virus (HIV) pandemic. Little has been described on the JCV‐TCR sequences from PML‐HIV‐negative patients affected by other immunosuppressive disorders. The aim of this study was to analyze the JCV‐TCR detected in CSF samples from 12 HIV‐negative immunosuppressed patients suffering from PML and to investigate the possible role of genomic organization in the different incidences of PML in HIV‐positive and HIV‐negative patients. The results confirm that the JCV‐TCR rearrangements play a crucial role in the development of PML, although they do not account for the higher frequency of the disease in HIV infection. These data support the hypothesis that, independently of the rearrangement patterns of JCV‐TCR, the direct action of HIV together with other as yet unidentified cellular determinants can be a key to explaining the high rate of PML in HIV infection with respect to other underlying immunosuppressive conditions. J. Med. Virol. 78:1271–1275, 2006.
- 1 October 2003
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 9 (5) , 551-558
Identical Rearranged Forms of JC Polyomavirus Transcriptional Control Region in Plasma and Cerebrospinal Fluid of Acquired Immunodeficiency Syndrome Patients with Progressive Multifocal Leukoencephalopathy
Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease of the central nervous system (CNS) caused by the human polyomavirus JC (JCV). JCV has a hypervariable noncoding transcriptional control region (TCR) that spans the origin of replication of the JCV genome through to the first ATG start codon for late gene transcription. The archetype form of TCR is frequently found in the urine and kidneys of healthy and immunocompromised subjects. However the rearranged forms, whose prototype is Mad-1, possibly generated by deletion and duplication of segments of the archetype sequence, are found in the brain and cerebrospinal fluid (CSF) of PML patients. In this study the authors compared JCVTCR detected in paired CSF, plasma, and urine samples of 11 acquired immunodeficiency syndrome (AIDS) patients affected by PML to try to determine where the rearranged JCV TCRs are selected. In one patient, it was also possible to amplify and sequence the TCR in the brain and lymphocytes. Moreover, in 5/11 patients, the CSF, plasma, and urine samples corresponding to 2 months after PML development were available; and in another patient, it was possible to sequence the TCR in plasma and lymphocytes sampled 8 months before the onset of PML. The presence of the same TCR sequences in all the CSF and plasma samples taken from individual patients could strengthen the hypothesis that the blood is a compartment where JCV may replicate and undergo rearrangement of the TCR. This further supports the hypothesis that JCV reaches the brain by a hematogenous route and indicates that the JCV TCR sequences detected in plasma could be used as an early marker of JCV pathogenicity before the clinical appearance of PML in immunocompromised patients.
- 1 October 2003
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 9 (5) , 551-558
Identical Rearranged Forms of JC Polyomavirus Transcriptional Control Region in Plasma and Cerebrospinal Fluid of Acquired Immunodeficiency Syndrome Patients with Progressive Multifocal Leukoencephalopathy
Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease of the central nervous system (CNS) caused by the human polyomavirus JC (JCV). JCV has a hypervariable noncoding transcriptional control region (TCR) that spans the origin of replication of the JCV genome through to the first ATG start codon for late gene transcription. The archetype form of TCR is frequently found in the urine and kidneys of healthy and immunocompromised subjects. However the rearranged forms, whose prototype is Mad-1, possibly generated by deletion and duplication of segments of the archetype sequence, are found in the brain and cerebrospinal fluid (CSF) of PML patients. In this study the authors compared JCVTCR detected in paired CSF, plasma, and urine samples of 11 acquired immunodeficiency syndrome (AIDS) patients affected by PML to try to determine where the rearranged JCV TCRs are selected. In one patient, it was also possible to amplify and sequence the TCR in the brain and lymphocytes. Moreover, in 5/11 patients, the CSF, plasma, and urine samples corresponding to 2 months after PML development were available; and in another patient, it was possible to sequence the TCR in plasma and lymphocytes sampled 8 months before the onset of PML. The presence of the same TCR sequences in all the CSF and plasma samples taken from individual patients could strengthen the hypothesis that the blood is a compartment where JCV may replicate and undergo rearrangement of the TCR. This further supports the hypothesis that JCV reaches the brain by a hematogenous route and indicates that the JCV TCR sequences detected in plasma could be used as an early marker of JCV pathogenicity before the clinical appearance of PML in immunocompromised patients.